ATAD2 may be involved in the occurrence of nasopharyngeal carcinoma (NPC) by regulating the cell cycle and nucleic acid metabolism process, and it is also a molecular biomarker for the early diagnosis of NPC [61]. Here, ATAD2 is linked to nasopharyngeal carcinoma.